ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 138 filers reported holding ARCELLX INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,300,934 | +18.3% | 203,482 | +4.2% | 1.34% | +25.0% |
Q2 2023 | $6,174,121 | +35.7% | 195,260 | +32.2% | 1.07% | +8.2% |
Q1 2023 | $4,548,973 | +21.3% | 147,646 | +21.9% | 0.99% | -1.0% |
Q4 2022 | $3,751,461 | +42.9% | 121,093 | -13.4% | 1.00% | +33.9% |
Q3 2022 | $2,625,000 | -18.4% | 139,875 | -21.4% | 0.75% | -37.0% |
Q2 2022 | $3,218,000 | – | 178,000 | – | 1.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |